We are BrainScope
BrainScope is a medical neuro-technology company that is pioneering the assessment of brain injury, including concussion. The company’s innovative BrainScope One system
(FDA-cleared as Ahead 300) is an easy-to-use, non-invasive, hand-held platform that empowers physicians to make more accurate head injury assessments
quickly at the point-of-care.
 Subsequent labelling modification that clarified device capabilities with regard to “concussion/mTBI” in the Indications for Use was cleared on May 18, 2018 (K181179).
BrainScope has received the
Frost & Sullivan
2017 Best Practices Award
Traumatic Brain Injury Assessment
New Product Innovation
Click here to view report